The Wright Center is committed to fostering and maintaining industry-academic collaborations that are focused on the shared goal of improving the health of our communities. Our strategic collaborations with industry help us accelerate our mission of advancing science for the betterment of human health. Recent examples include:

Indivior Inc., which is headquartered in Richmond, has been developing medications to treat opioid use disorder for more than 20 years. Wright Center leadership is working with the specialty pharmaceuticals business on a clinical trial to test SUBLOCADE™ (buprenorphine extended-release) injection for subcutaneous use (CIII), a once-monthly injectable formulation of buprenorphine for the treatment of moderate-to-severe opioid use disorder. Read more about the collaboration here.

TriNetX is a platform that allows VCU clinical researchers to match clinical trial design with the patient population. Wright Center researchers partner with the global, federated health research network to proactively enhance study feasibility, study design and reach those participants who may qualify for a particular study. Read more about the collaboration here.

Cite & Submit: UL1TR002649

Publications supported by the Wright Center must cite the CTSA Grant number (UL1TR002649) and comply with the NIH Public Access Policy. We rely on these citations as a critical performance measure when reporting annual productivity to the NIH.

View graphic version